TrademarkOpen
Search / United States / 98201386

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Service Mark

ASKFIRST

Registered
Used for: Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve…
Show more

Class 35: Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve advances in therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trials
Class 45: Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing personal emotional support information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' families

Class 35 – Advertising & retailClass 45 – Legal & security services

Status timeline

  1. 2 Oct 2023
    Application filed
    New Application Entered
  2. 2 Feb 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 8 Feb 2024
    Office action issued
    Non-Final Action Written
  4. 8 Aug 2024
    Response to office action filed
    Teas Response To Office Action Received
  5. 9 Dec 2024
    Final refusal issued
    Final Refusal Mailed
  6. 8 Jan 2025
    Approved for publication
    Approved For Pub - Principal Register
  7. 28 Jan 2025
    Published for opposition
    Published For Opposition
  8. 25 Mar 2025
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  9. 16 Dec 2025
    Registered on the Principal Register
    Registered-Principal Register
  10. 17 Jun 2026
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
All 42 events
2026-07-28Notice Of Updated Registration Confirmation Emailed
2026-07-07Correction Under Section 7 - Processed
2026-06-17Automatic Update Of Assignment Of Ownership
2026-04-20Teas Response To Office Action-Post Reg Received
2026-04-19Post Registration Action Mailed - Sec. 7
2026-04-15Case Assigned To Post Registration Paralegal
2026-01-15Teas Section 7 Request Received
2025-12-16Registered-Principal Register
2025-12-16Notice Of Registration Confirmation Emailed
2025-11-21Case Assigned To Intent To Use Paralegal
2025-11-211(B) Basis Deleted; Proceed To Registration
2025-10-01Teas Post Publication Amendment Received
2025-10-01Notice Of Allowance Cancelled
2025-04-14Teas Post Publication Amendment Received
2025-03-25Noa Mailed - Sou Required From Applicant
2025-01-28Published For Opposition
2025-01-28Official Gazette Publication Confirmation E-Mailed
2025-01-22Notification Of Notice Of Publication E-Mailed
2025-01-08Approved For Pub - Principal Register
2025-01-07Teas Request For Reconsideration Received
2025-01-07Correspondence Received In Law Office
2025-01-07Teas/Email Correspondence Entered
2024-12-09Final Refusal Mailed
2024-12-09Final Refusal E-Mailed
2024-12-09Notification Of Final Refusal Emailed
2024-11-04Assigned To Lie
2024-11-04Correspondence Received In Law Office
2024-11-04Teas/Email Correspondence Entered
2024-08-08Teas Response To Office Action Received
2024-05-08Application Extension To Response Period - Received
2024-05-08Application Extension Granted/Receipt Provided
2024-05-08Teas Change Of Owner Address Received
2024-05-08Applicant/Correspondence Changes (Non-Responsive) Entered
2024-05-08Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-05-08Attorney/Dom.rep.revoked And/Or Appointed
2024-05-08Teas Change Of Correspondence Received
2024-02-08Non-Final Action Written
2024-02-08Non-Final Action E-Mailed
2024-02-08Notification Of Non-Final Action E-Mailed
2024-02-02Assigned To Examiner
2023-10-11New Application Office Supplied Data Entered
2023-10-02New Application Entered

Goods & services by class

Class 35 Advertising & retail

Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve advances in therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trials

First use anywhere 14 Jun 2020 · First use in commerce 14 Jun 2020

Class 45 Legal & security services

Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing personal emotional support information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' families

First use anywhere 14 Jun 2020 · First use in commerce 14 Jun 2020

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 28 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.